Targeted systemic delivery of innate immune activators: A Deep Dive in Targets for Cancer IO

When:  Aug 26, 2022 from 10:00 to 12:00 (CT)
This webinar, the fourth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the targeted systemic delivery of innate immune activators. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target audience of this series.

Moderators:
  • Timothy Lowinger, PhD – Mersana Therapeutics
  • Valerie Odegard, PhD – Silverback Therapeutics
Faculty:
  • TBD

Learn more about the 2022 Targets for Cancer IO: A Deep Dive Series here!

Targets for Cancer IO: A Deep Dive Series is supported, in part, by educational grants from Genmab, US, Inc. and Merck & Co., Inc. (as of 6/6/2022).

#TargetsforCancerImmunotherapyADeepDiveSeminarSeries #NoCEOffered #Industry #Researcher #2022